News
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks ...
In the cutthroat pharmaceutical arena, Pfizer stands poised for a strategic pivot and a potential earnings bonanza in 2025.
A $150 million redevelopment plan will convert the former Pfizer campus in Peapack-Gladstone into a senior living community.
23h
Zacks Investment Research on MSNPfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?Wall Street expects a year-over-year decline in earnings on higher revenues when Pfizer (PFE) reports results for the quarter ...
Scientists in Turkey found that the Pfizer COVID-19 vaccine impacted some people's corneas, according to a study.
Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...
22h
Barchart on MSNPfizer Stock: Analyst Estimates & RatingsPfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...
The move is expected to cause a “near-term stock out of Bicillin L-A,” Pfizer said in its statement, with the drugmaker now ...
BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
I can’t ask you to do that because we are still on the verge of finding out what the Seagen acquisition does. Let’s give Dr.
A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 ...
Pfizer's innovations include vaccines, medicines, energy, and biodiversity projects, driven by their ESG Strategy and sustainability initiatives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results